|
1
|
McLaughlin VV, Archer SL, Badesch DB, et
al: ACCF/AHA 2009 expert consensus document on pulmonary
hypertension: a report of the American College of Cardiology
Foundation Task Force on Expert Consensus Documents and the
American Heart Association developed in collaboration with the
American College of Chest Physicians; American Thoracic Society,
Inc.; and the Pulmonary Hypertension Association. J Am Coll
Cardiol. 53:1573–1619. 2009.
|
|
2
|
Galiè N, Hoeper MM, Humbert M, et al; ESC
Committee for Practice Guidelines (CPG). Guidelines for the
diagnosis and treatment of pulmonary hypertension: the Task Force
for the Diagnosis and Treatment of Pulmonary Hypertension of the
European Society of Cardiology (ESC) and the European Respiratory
Society (ERS), endorsed by the International Society of Heart and
Lung Transplantation (ISHLT). Eur Heart J. 30:2493–2537. 2009.
|
|
3
|
Guillinta P, Peterson KL and Ben-Yehuda O:
Cardiac catheterization techniques in pulmonary hypertension.
Cardiol Clin. 22:401–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seino Y, Ogawa A, Yamashita T, et al:
Application of NT-proBNP and BNP measurements in cardiac care: a
more discerning marker for the detection and evaluation of heart
failure. Eur J Heart Fail. 6:295–300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pruszczyk P: N-terminal pro-brain
natriuretic peptide as an indicator of right ventricular
dysfunction. J Card Fail. 11(5 Suppl): S65–S69. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fijalkowska A, Kurzyna M, Torbicki A, et
al: Serum N-terminal brain natriuretic peptide as a prognostic
parameter in patients with pulmonary hypertension. Chest.
129:1313–1321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Casserly B and Klinger JR: Brain
natriuretic peptide in pulmonary arterial hypertension: biomarker
and potential therapeutic agent. Drug Des Devel Ther. 29:269–287.
2009.PubMed/NCBI
|
|
8
|
Hoey ET, Gopalan D, Agrawal SK and
Screaton NJ: Cardiac causes of pulmonary arterial hypertension:
assessment with multidetector CT. Eur Radiol. 19:2557–2568. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghuysen A, Ghaye B, Willems V, et al:
Computed tomographic pulmonary angiography and prognostic
significance in patients with acute pulmonary embolism. Thorax.
60:956–961. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collomb D, Paramelle PJ, Calaque O, et al:
Severity assessment of acute pulmonary embolism: evaluation using
helical CT. Eur Radiol. 13:1508–1514. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nural MS, Elmali M, Findik S, et al:
Computed tomographic pulmonary angiography in the assessment of
severity of acute pulmonary embolism and right ventricular
dysfunction. Acta Radiol. 50:629–637. 2009. View Article : Google Scholar
|
|
12
|
Johnson TR, Nikolaou K, Becker A, Leber
AW, Rist C, Wintersperger BJ, Reiser MF and Becker CR: Dual-source
CT for chest pain assessment. Eur Radiol. 18:773–780.
2008.PubMed/NCBI
|
|
13
|
Revel MP, Faivre JB, Remy-Jardin M,
Delannoy-Deken V, Duhamel A and Remy J: Pulmonary hypertension:
ECG-gated 64-section CT angiographic evaluation of new functional
parameters as diagnostic criteria. Radiology. 250:558–566. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Doğan H, Kroft LJ, Huisman MV, van der
Geest RJ and de Roos A: Right ventricular function in patients with
acute pulmonary embolism: analysis with
electrocardiography-synchronized multi-detector row CT. Radiology.
242:78–84. 2007.PubMed/NCBI
|
|
15
|
Liu M, Ma Z, Guo X, Zhang H, Yang Y and
Wang C: Computed tomographic pulmonary angiography in the
assessment of severity of chronic thromboembolic pulmonary
hypertension and right ventricular dysfunction. Eur J Radiol.
80:e462–e469. 2011. View Article : Google Scholar
|
|
16
|
Liu M, Ma ZH, Guo XJ, et al: A septal
angle measured on computed tomographic pulmonary angiography can
noninvasively estimate pulmonary vascular resistance in patients
with chronic thromboembolic pulmonary hypertension. J Thorac
Imaging. 27:325–330. 2012. View Article : Google Scholar
|
|
17
|
Liu M, Ma Z, Guo X, Chen X, Yang Y and
Wang C: Cardiovascular parameters of computed tomographic pulmonary
angiography to assess pulmonary vascular resistance in patients
with chronic thromboembolic pulmonary hypertension. Int J Cardiol.
164:295–300. 2013. View Article : Google Scholar
|
|
18
|
Tramarin R, Torbicki A, Marchandise B,
Laaban JP and Morpurgo M; Working Group on Noninvasive Evaluation
of Pulmonary Artery Pressure. European Office of the World Health
Organization, Copenhagen. Doppler echocardiographic evaluation of
pulmonary artery pressure in chronic obstructive pulmonary disease.
A European multicentre study. Eur Heart J. 12:103–111. 1991.
|
|
19
|
Ganz W, Donoso R, Marcus HS, Forrester JS
and Swan HJ: A new technique for measurement of cardiac output by
thermodilution in man. Am J Cardiol. 27:392–396. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McMichael J and Sharpey-Schafer EP:
Cardiac output in man by a direct fick method: Effects of posture,
venous pressure change, atropine, and adrenaline. Br Heart J.
6:33–40. 1944. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bogaard HJ, Abe K, Vonk Noordegraaf A and
Voelkel NF: The right ventricle under pressure: cellular and
molecular mechanisms of right-heart failure in pulmonary
hypertension. Chest. 135:794–804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Delcroix M, Vonk Noordegraaf A, Fadel E,
Lang I, Simonneau G and Naeije R: Vascular and right ventricular
remodelling in chronic thromboembolic pulmonary hypertension. Eur
Respir J. 41:224–232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sitbon O, Humbert M, Nunes H, et al:
Long-term intravenous epoprostenol infusion in primary pulmonary
hypertension: prognostic factors and survival. J Am Coll Cardiol.
40:780–788. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raymond RJ, Hinderliter AL, Willis PW,
Ralph D, et al: Echocardiographic predictors of adverse outcomes in
primary pulmonary hypertension. J Am Coll Cardiol. 39:1214–1219.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McGoon M, Gutterman D, Steen V, Barst R,
et al: Screening, early detection, and diagnosis of pulmonary
arterial hypertension: ACCP evidence based clinical practice
guidelines. Chest. 126(1 Suppl): 14S–34S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Andreassen AK, Wergeland R, Simonsen S,
Geiran O, Guevara C and Ueland T: N-terminal pro-B-type natriuretic
peptide as an indicator of disease severity in a heterogeneous
group of patients with chronic precapillary pulmonary hypertension.
Am J Cardiol. 98:525–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagaya N, Nishikimi T, Okano Y, et al:
Plasma brain natriuretic peptide levels increase in proportion to
the extent of right ventricular dysfunction in pulmonary
hypertension. J Am Coll Cardiol. 31:202–208. 1998. View Article : Google Scholar
|
|
28
|
McDonagh TA, Holmer S, Raymond I, Luchner
A, Hildebrant P and Dargie HJ: NT-proBNP and the diagnosis of heart
failure: a pooled analysis of three European epidemiological
studies. Eur J Heart Fail. 6:269–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yap LB, Ashrafian H, Mukerjee D, Coghlan
JG and Timms PM: The natriuretic peptides and their role in
disorders of right heart dysfunction and pulmonary hypertension.
Clin Biochem. 37:847–856. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
D'Armini AM, Cattadori B, Monterosso C, et
al: Pulmonary thromboendarterectomy in patients with chronic
thromboembolic pulmonary hypertension: hemodynamic characteristics
and changes. Eur J Cardiothorac Surg. 18:696–702. 2000. View Article : Google Scholar
|
|
31
|
Reesink HJ, Tulevski II, Marcus JT,
Boomsma F, et al: Brain natriuretic peptide as noninvasive marker
of the severity of right ventricular dysfunction in chronic
thromboembolic pulmonary hypertension. Ann Thorac Surg. 84:537–543.
2007. View Article : Google Scholar
|
|
32
|
Jamieson SW, Kapelanski DP, Sakakibara N,
et al: Pulmonary endarterectomy: experience and lessons learned in
1,500 cases. Ann Thorac Surg. 76:1457–1464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Badesch DB, Champion HC, Sanchez MA, et
al: Diagnosis and assessment of pulmonary arterial hypertension. J
Am Coll Cardiol. 54(1 Suppl): S55–S66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mukerjee D, Yap LB, Holmes AM, Nair D, et
al: Significance of plasma N-terminal pro-brain natriuretic peptide
in patients with systemic sclerosis-related pulmonary arterial
hypertension. Respir Med. 97:1230–1236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Souza R, Jardim C, Julio Cesar Fernandes
C, Silveira Lapa M, et al: NT-proBNP as a tool to stratify disease
severity in pulmonary arterial hypertension. Respir Med. 101:69–75.
2007. View Article : Google Scholar : PubMed/NCBI
|
